These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 17428359

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S, Maeda A, Ito H, Omata M, Yamada H, Ozaki S.
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [Abstract] [Full Text] [Related]

  • 3. Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
    de Menthon M, Cohen P, Pagnoux C, Buchler M, Sibilia J, Détrée F, Gayraud M, Khellaf M, Penalba C, Legallicier B, Mouthon L, Guillevin L.
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S63-71. PubMed ID: 21586199
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Wegener's granulomatosis effectively treated with rituximab: a case study.
    Kowalewska B, Szechiński J, Roszkowska E.
    Pol Arch Med Wewn; 2008 Jun; 118(6):381-5. PubMed ID: 18619196
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of ANCA-associated vascularitides].
    Guillevin L, Pagnoux C.
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [Abstract] [Full Text] [Related]

  • 7. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D.
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [Abstract] [Full Text] [Related]

  • 8. Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective.
    Joshi L, Lightman SL, Salama AD, Shirodkar AL, Pusey CD, Taylor SR.
    Ophthalmology; 2011 Dec; 118(12):2498-503. PubMed ID: 21907416
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL, Puéchal X, Pugnet G, London J, Terrier B, Charles P, Mouthon L, Guillevin L, French Vasculitis Study Group.
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
    Recillas-Gispert C, Serna-Ojeda JC, Flores-Suárez LF.
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
    Azar L, Springer J, Langford CA, Hoffman GS.
    Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
    [Abstract] [Full Text] [Related]

  • 17. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H, Lee SM, Manno RL, Seo P, Geetha D.
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
    Avshovich N, Boulman N, Slobodin G, Zeina AR, Rosner I, Rozenbaum M.
    Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
    [No Abstract] [Full Text] [Related]

  • 20. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
    Eriksson P.
    J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.